BlackRock’s Agile Therapeutics AGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,745
Closed -$11.2K 5492
2023
Q4
$11.2K Sell
5,745
-295
-5% -$593 ﹤0.01% 5134
2023
Q3
$14.5K Sell
6,040
-21
-0.3% -$52 ﹤0.01% 5176
2023
Q2
$17.9K Sell
6,061
-2
-0% -$11 ﹤0.01% 5210
2023
Q1
$67.9K Sell
6,063
-6
-0.1% -$77 ﹤0.01% 5054
2022
Q4
$68.9K Sell
6,069
-7
-0.1% -$81 ﹤0.01% 5147
2022
Q3
$91K Buy
6,076
+5,125
+539% +$126K ﹤0.01% 5202
2022
Q2
$56K Buy
951
+189
+25% +$27.4K ﹤0.01% 5393
2022
Q1
$319K Buy
762
+8
+1% +$5.11K ﹤0.01% 4994
2021
Q4
$736K Buy
754
+19
+3% +$26.8K ﹤0.01% 4756
2021
Q3
$1.41M Buy
735
+81
+12% +$183K ﹤0.01% 4462
2021
Q2
$1.74M Sell
654
-1,895
-74% -$6.25M ﹤0.01% 4339
2021
Q1
$10.6M Sell
2,549
-12
-0.5% -$64.9K ﹤0.01% 3534
2020
Q4
$14.7M Buy
2,561
+9
+0.4% +$53K ﹤0.01% 3177
2020
Q3
$15.5M Sell
2,552
-17
-0.7% -$97.4K ﹤0.01% 3012
2020
Q2
$14.3M Buy
2,569
+1,940
+308% +$10.1M ﹤0.01% 2988
2020
Q1
$2.34M Buy
629
+151
+32% +$867K ﹤0.01% 3606
2019
Q4
$2.39M Buy
478
+394
+469% +$1.38M ﹤0.01% 3738
2019
Q3
$199K Sell
84
-1
-1% -$2.46K ﹤0.01% 4329
2019
Q2
$247K Buy
85
+18
+27% +$50.3K ﹤0.01% 4334
2019
Q1
$201K Hold
67
﹤0.01% 4239
2018
Q4
$77K Buy
67
+9
+16% +$13.8K ﹤0.01% 4403
2018
Q3
$42K Buy
58
+2
+4% +$1.46K ﹤0.01% 4566
2018
Q2
$56K Sell
56
-4
-7% -$14K ﹤0.01% 4546
2018
Q1
$308K Buy
60
+4
+7% +$26.4K ﹤0.01% 4120
2017
Q4
$302K Buy
56
+2
+4% +$18.6K ﹤0.01% 4128
2017
Q3
$486K Buy
54
+23
+74% +$177K ﹤0.01% 4066
2017
Q2
$235K Sell
31
-287
-90% -$1.99M ﹤0.01% 4216
2017
Q1
$2.04M Buy
+318
New +$1.6M ﹤0.01% 3649
2016
Q4
Hold
0
3613
2016
Q3
Hold
0
3533
2016
Q2
Hold
0
3551
2016
Q1
Hold
0
3587

Other funds holding AGRX